Search

everythinglearnresearchcommunity

for

Search:↓

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

The research reveals how early embryonic mouse skin develops from simple to complex structures, identifying various cell types and their roles in this process.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Recognizing skin symptoms can help diagnose and manage COVID-19.

These gene variations are not linked to alopecia areata in Egyptians.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Nerves and chemicals in the body can affect hair growth and loss.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

FFA's causes may include environmental triggers and genetic factors.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.